Requirements for efficient correction of Δf508 CFTR revealed by analyses of evolved sequences

Juan L. Mendoza, André Schmidt, Qin Li, Emmanuel Nuvaga, Tyler Barrett, Robert J. Bridges, Andrew P Feranchak, Chad A Brautigam, Philip J Thomas

Research output: Contribution to journalArticle

161 Citations (Scopus)

Abstract

Misfolding of ΔF508 cystic fibrosis (CF) transmembrane conductance regulator (CFTR) underlies pathology in most CF patients. F508 resides in the first nucleotide-binding domain (NBD1) of CFTR near a predicted interface with the fourth intracellular loop (ICL4). Efforts to identify small molecules that restore function by correcting the folding defect have revealed an apparent efficacy ceiling. To understand the mechanistic basis of this obstacle, positions statistically coupled to 508, in evolved sequences, were identified and assessed for their impact on both NBD1 and CFTR folding. The results indicate that both NBD1 folding and interaction with ICL4 are altered by the ΔF508 mutation and that correction of either individual process is only partially effective. By contrast, combination of mutations that counteract both defects restores ΔF508 maturation and function to wild-type levels. These results provide a mechanistic rationale for the limited efficacy of extant corrector compounds and suggest approaches for identifying compounds that correct both defective steps.

Original languageEnglish (US)
Pages (from-to)164-174
Number of pages11
JournalCell
Volume148
Issue number1-2
DOIs
StatePublished - Jan 20 2012

Fingerprint

Sequence Analysis
Cystic Fibrosis Transmembrane Conductance Regulator
Defects
Mutation
Ceilings
Pathology
Cystic Fibrosis
Nucleotides
Molecules

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Mendoza, J. L., Schmidt, A., Li, Q., Nuvaga, E., Barrett, T., Bridges, R. J., ... Thomas, P. J. (2012). Requirements for efficient correction of Δf508 CFTR revealed by analyses of evolved sequences. Cell, 148(1-2), 164-174. https://doi.org/10.1016/j.cell.2011.11.023

Requirements for efficient correction of Δf508 CFTR revealed by analyses of evolved sequences. / Mendoza, Juan L.; Schmidt, André; Li, Qin; Nuvaga, Emmanuel; Barrett, Tyler; Bridges, Robert J.; Feranchak, Andrew P; Brautigam, Chad A; Thomas, Philip J.

In: Cell, Vol. 148, No. 1-2, 20.01.2012, p. 164-174.

Research output: Contribution to journalArticle

Mendoza, JL, Schmidt, A, Li, Q, Nuvaga, E, Barrett, T, Bridges, RJ, Feranchak, AP, Brautigam, CA & Thomas, PJ 2012, 'Requirements for efficient correction of Δf508 CFTR revealed by analyses of evolved sequences', Cell, vol. 148, no. 1-2, pp. 164-174. https://doi.org/10.1016/j.cell.2011.11.023
Mendoza JL, Schmidt A, Li Q, Nuvaga E, Barrett T, Bridges RJ et al. Requirements for efficient correction of Δf508 CFTR revealed by analyses of evolved sequences. Cell. 2012 Jan 20;148(1-2):164-174. https://doi.org/10.1016/j.cell.2011.11.023
Mendoza, Juan L. ; Schmidt, André ; Li, Qin ; Nuvaga, Emmanuel ; Barrett, Tyler ; Bridges, Robert J. ; Feranchak, Andrew P ; Brautigam, Chad A ; Thomas, Philip J. / Requirements for efficient correction of Δf508 CFTR revealed by analyses of evolved sequences. In: Cell. 2012 ; Vol. 148, No. 1-2. pp. 164-174.
@article{47a77f5e47454cfe98f9d67152f16ada,
title = "Requirements for efficient correction of Δf508 CFTR revealed by analyses of evolved sequences",
abstract = "Misfolding of ΔF508 cystic fibrosis (CF) transmembrane conductance regulator (CFTR) underlies pathology in most CF patients. F508 resides in the first nucleotide-binding domain (NBD1) of CFTR near a predicted interface with the fourth intracellular loop (ICL4). Efforts to identify small molecules that restore function by correcting the folding defect have revealed an apparent efficacy ceiling. To understand the mechanistic basis of this obstacle, positions statistically coupled to 508, in evolved sequences, were identified and assessed for their impact on both NBD1 and CFTR folding. The results indicate that both NBD1 folding and interaction with ICL4 are altered by the ΔF508 mutation and that correction of either individual process is only partially effective. By contrast, combination of mutations that counteract both defects restores ΔF508 maturation and function to wild-type levels. These results provide a mechanistic rationale for the limited efficacy of extant corrector compounds and suggest approaches for identifying compounds that correct both defective steps.",
author = "Mendoza, {Juan L.} and Andr{\'e} Schmidt and Qin Li and Emmanuel Nuvaga and Tyler Barrett and Bridges, {Robert J.} and Feranchak, {Andrew P} and Brautigam, {Chad A} and Thomas, {Philip J}",
year = "2012",
month = "1",
day = "20",
doi = "10.1016/j.cell.2011.11.023",
language = "English (US)",
volume = "148",
pages = "164--174",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "1-2",

}

TY - JOUR

T1 - Requirements for efficient correction of Δf508 CFTR revealed by analyses of evolved sequences

AU - Mendoza, Juan L.

AU - Schmidt, André

AU - Li, Qin

AU - Nuvaga, Emmanuel

AU - Barrett, Tyler

AU - Bridges, Robert J.

AU - Feranchak, Andrew P

AU - Brautigam, Chad A

AU - Thomas, Philip J

PY - 2012/1/20

Y1 - 2012/1/20

N2 - Misfolding of ΔF508 cystic fibrosis (CF) transmembrane conductance regulator (CFTR) underlies pathology in most CF patients. F508 resides in the first nucleotide-binding domain (NBD1) of CFTR near a predicted interface with the fourth intracellular loop (ICL4). Efforts to identify small molecules that restore function by correcting the folding defect have revealed an apparent efficacy ceiling. To understand the mechanistic basis of this obstacle, positions statistically coupled to 508, in evolved sequences, were identified and assessed for their impact on both NBD1 and CFTR folding. The results indicate that both NBD1 folding and interaction with ICL4 are altered by the ΔF508 mutation and that correction of either individual process is only partially effective. By contrast, combination of mutations that counteract both defects restores ΔF508 maturation and function to wild-type levels. These results provide a mechanistic rationale for the limited efficacy of extant corrector compounds and suggest approaches for identifying compounds that correct both defective steps.

AB - Misfolding of ΔF508 cystic fibrosis (CF) transmembrane conductance regulator (CFTR) underlies pathology in most CF patients. F508 resides in the first nucleotide-binding domain (NBD1) of CFTR near a predicted interface with the fourth intracellular loop (ICL4). Efforts to identify small molecules that restore function by correcting the folding defect have revealed an apparent efficacy ceiling. To understand the mechanistic basis of this obstacle, positions statistically coupled to 508, in evolved sequences, were identified and assessed for their impact on both NBD1 and CFTR folding. The results indicate that both NBD1 folding and interaction with ICL4 are altered by the ΔF508 mutation and that correction of either individual process is only partially effective. By contrast, combination of mutations that counteract both defects restores ΔF508 maturation and function to wild-type levels. These results provide a mechanistic rationale for the limited efficacy of extant corrector compounds and suggest approaches for identifying compounds that correct both defective steps.

UR - http://www.scopus.com/inward/record.url?scp=84862909346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862909346&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2011.11.023

DO - 10.1016/j.cell.2011.11.023

M3 - Article

C2 - 22265409

AN - SCOPUS:84862909346

VL - 148

SP - 164

EP - 174

JO - Cell

JF - Cell

SN - 0092-8674

IS - 1-2

ER -